Global B7-H4 Antibody Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global B7-H4 Antibody Market Insights, Forecast to 2034
B7-H4 Antibody is an antibody directed against the B7-H4 protein in the human immune system.
Market Analysis and InsightsGlobal B7-H4 Antibody Market
Global B7-H4 Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, B7-H4 Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
B7-H4, also known as VTCN1, belongs to the B7 family of immune checkpoint molecules and is usually expressed in antigen-presenting cells, tumor cells and certain inflammation-related cells. Its role is to maintain immune balance by regulating T cell immune responses, thereby potentially suppressing excessive immune responses. B7-H4 antibodies can bind to B7-H4 molecules, and may play a role in regulating T cell activation, proliferation and suppressing immune responses. Therefore, this antibody has potential application prospects in the research of immune diseases, tumor therapy and other fields.
Report Covers
This report presents an overview of global B7-H4 Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global B7-H4 Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
BioLegend
Thermo Fisher
Abcam
Cell Signaling Technology, Inc.
CUSABIO
MyBiosource, Inc.
Biotium
Merck
Abeomics Inc.
HUABIO
Abbiotec
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, B7-H4 Antibody introduction, etc. B7-H4 Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of B7-H4 Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal B7-H4 Antibody Market
Global B7-H4 Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, B7-H4 Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
B7-H4, also known as VTCN1, belongs to the B7 family of immune checkpoint molecules and is usually expressed in antigen-presenting cells, tumor cells and certain inflammation-related cells. Its role is to maintain immune balance by regulating T cell immune responses, thereby potentially suppressing excessive immune responses. B7-H4 antibodies can bind to B7-H4 molecules, and may play a role in regulating T cell activation, proliferation and suppressing immune responses. Therefore, this antibody has potential application prospects in the research of immune diseases, tumor therapy and other fields.
Report Covers
This report presents an overview of global B7-H4 Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global B7-H4 Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
BioLegend
Thermo Fisher
Abcam
Cell Signaling Technology, Inc.
CUSABIO
MyBiosource, Inc.
Biotium
Merck
Abeomics Inc.
HUABIO
Abbiotec
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, B7-H4 Antibody introduction, etc. B7-H4 Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of B7-H4 Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports